Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Merck & Co Q1 2024 Adj EPS $2.07 Beats $1.88 Estimate, Sales $15.775B Beat $15.196B Estimate

Author: Benzinga Newsdesk | April 25, 2024 06:31am
Merck & Co (NYSE:MRK) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $1.88 by 10.11 percent. This is a 47.86 percent increase over earnings of $1.40 per share from the same period last year. The company reported quarterly sales of $15.775 billion which beat the analyst consensus estimate of $15.196 billion by 3.81 percent. This is a 8.89 percent increase over sales of $14.487 billion the same period last year.

Posted In: MRK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist